http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015201676-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1ccdf23e43f6658515fe6995f93b21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70204eac846a7f0c7a310cf16dedb3f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca41c3b451c70907b44bf10fb722c42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deba5a8e39be9ea24b2aa9fa145539ce |
publicationDate | 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2015201676-A1 |
titleOfInvention | Anti-C5a antibodies and methods for using the antibodies |
abstract | The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospho lipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease. |
priorityDate | 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 704.